These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16500033)

  • 1. The potential efficacy of omega-3 fatty acids as anti-angiogenic agents in benign vascular tumors of infancy.
    Sterescu AE; Rousseau-Harsany E; Farrell C; Powell J; David M; Dubois J
    Med Hypotheses; 2006; 66(6):1121-4. PubMed ID: 16500033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids.
    Rose DP; Connolly JM
    Nutr Cancer; 2000; 37(2):119-27. PubMed ID: 11142082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential.
    Spencer L; Mann C; Metcalfe M; Webb M; Pollard C; Spencer D; Berry D; Steward W; Dennison A
    Eur J Cancer; 2009 Aug; 45(12):2077-86. PubMed ID: 19493674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemangiomas - current therapeutic strategies.
    Mabeta P; Pepper MS
    Int J Dev Biol; 2011; 55(4-5):431-7. PubMed ID: 21858768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids, inflammation and angiogenesis: nutrigenomic effects as an explanation for anti-atherogenic and anti-inflammatory effects of fish and fish oils.
    Massaro M; Scoditti E; Carluccio MA; Montinari MR; De Caterina R
    J Nutrigenet Nutrigenomics; 2008; 1(1-2):4-23. PubMed ID: 19918111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas.
    Jia J; Zhao YF; Zhao JH
    Med Hypotheses; 2007; 68(2):288-90. PubMed ID: 17010532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic diseases.
    Billington DC
    Drug Des Discov; 1991 Nov; 8(1):3-35. PubMed ID: 1725722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The present and future of angiogenesis-directed treatments of colorectal cancer.
    O'Dwyer PJ
    Oncologist; 2006 Oct; 11(9):992-8. PubMed ID: 17030640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy.
    Greenberg JI; Cheresh DA
    Expert Opin Biol Ther; 2009 Nov; 9(11):1347-56. PubMed ID: 19761418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting angiogenesis for the treatment of sarcoma.
    Balasubramanian L; Evens AM
    Curr Opin Oncol; 2006 Jul; 18(4):354-9. PubMed ID: 16721130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
    Liekens S
    Verh K Acad Geneeskd Belg; 2002; 64(3):197-224. PubMed ID: 12238243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a new understanding of vascular proliferative disease in children.
    Folkman J
    Pediatrics; 1984 Nov; 74(5):850-6. PubMed ID: 6208529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E; Honoré S; Braguer D
    Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial.
    Pope E; Krafchik BR; Macarthur C; Stempak D; Stephens D; Weinstein M; Ho N; Baruchel S
    Pediatrics; 2007 Jun; 119(6):e1239-47. PubMed ID: 17485449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
    Crawford Y; Ferrara N
    Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.